JP4383855B2 - パイエル板および／またはｍ細胞を標的とするリガンド - Google Patents

パイエル板および／またはｍ細胞を標的とするリガンド Download PDF

Info

Publication number
JP4383855B2
JP4383855B2 JP2003510683A JP2003510683A JP4383855B2 JP 4383855 B2 JP4383855 B2 JP 4383855B2 JP 2003510683 A JP2003510683 A JP 2003510683A JP 2003510683 A JP2003510683 A JP 2003510683A JP 4383855 B2 JP4383855 B2 JP 4383855B2
Authority
JP
Japan
Prior art keywords
seq
peptide
synthetic polypeptide
amino acid
purified synthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2003510683A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005503782A (ja
JP2005503782A5 (https=
Inventor
オマホニー、ダニエル
ランブキン、イメルダ
ヒギンズ、リサ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merrion Research Ill Ltd
Original Assignee
Merrion Research Ill Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrion Research Ill Ltd filed Critical Merrion Research Ill Ltd
Publication of JP2005503782A publication Critical patent/JP2005503782A/ja
Publication of JP2005503782A5 publication Critical patent/JP2005503782A5/ja
Application granted granted Critical
Publication of JP4383855B2 publication Critical patent/JP4383855B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4725—Proteoglycans, e.g. aggreccan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
JP2003510683A 2001-07-02 2002-06-28 パイエル板および／またはｍ細胞を標的とするリガンド Expired - Fee Related JP4383855B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30259101P 2001-07-02 2001-07-02
PCT/IB2002/003401 WO2003004517A2 (en) 2001-07-02 2002-06-28 Peyers's patch and/or m-celle targeting ligands

Publications (3)

Publication Number Publication Date
JP2005503782A JP2005503782A (ja) 2005-02-10
JP2005503782A5 JP2005503782A5 (https=) 2008-12-18
JP4383855B2 true JP4383855B2 (ja) 2009-12-16

Family

ID=23168408

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003510683A Expired - Fee Related JP4383855B2 (ja) 2001-07-02 2002-06-28 パイエル板および／またはｍ細胞を標的とするリガンド

Country Status (8)

Country Link
US (3) US6916789B2 (https=)
EP (1) EP1432729B1 (https=)
JP (1) JP4383855B2 (https=)
AT (1) ATE414100T1 (https=)
AU (1) AU2002326070A1 (https=)
CA (1) CA2451741C (https=)
DE (1) DE60229867D1 (https=)
WO (1) WO2003004517A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6521737B1 (en) * 1995-11-10 2003-02-18 Elan Corporation, Plc Peptides which enhance transport across tissues and methods of identifying and using the same
ATE414100T1 (de) * 2001-07-02 2008-11-15 Merrion Res Iii Ltd Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen
WO2004108755A2 (en) * 2003-06-10 2004-12-16 University Of Saskatchewan Chimeric adenovirus capsid proteins
AU2012201102B2 (en) * 2004-06-23 2014-05-08 Ferguson, Ian Andrew Agents and methods for early diagnosis and monitoring of Alzheimer's disease and other neurological disorders
DE102005031755B9 (de) * 2005-07-01 2010-04-08 Technische Universität Dresden Salmonella spp. bindende Peptide, dafür kodierende Nukleinsäuren, deren Verwendungen und Verfahren und Kits zur Anreicherung, Immobilisierung und zum Nachweis von Salmonella spp.
WO2007137174A2 (en) * 2006-05-18 2007-11-29 The Ohio State University Research Foundation Compositions and methods for the detection of vulnerable plaque
CN104884065B (zh) 2012-09-21 2019-01-01 强烈治疗剂公司 治疗癌症的方法
JP6618892B2 (ja) 2013-04-23 2019-12-11 プレジデント アンド フェローズ オブ ハーバード カレッジ 細菌バイオフィルムの遺伝的リプログラミング
EP3280397A4 (en) 2015-04-06 2018-08-22 President and Fellows of Harvard College Biosynthetic amyloid-based materials displaying functional protein sequences
US11098133B2 (en) 2016-05-19 2021-08-24 President And Fellows Of Harvard College Methods of making gels and films using curli nanofibers
TW201829470A (zh) 2016-10-26 2018-08-16 廖朝暐 用於免疫增強的融合胜肽及使用其增強誘發免疫反應的方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986004608A1 (en) * 1985-02-05 1986-08-14 Synergen Biologicals, Inc. Metalloproteinase inhibitor sequence recombinant vector system for using same and recombinant-dna method for the manufacture of same
IL84167A (en) * 1986-10-24 1991-04-15 Southern Res Inst Oral delivery of bioactive agents to and through the peyer's patch by use of microencapsulation
US5254342A (en) 1991-09-30 1993-10-19 University Of Southern California Compositions and methods for enhanced transepithelial and transendothelial transport or active agents
GB9201139D0 (en) * 1992-01-20 1992-03-11 Connaught Lab Synthetic peptides for a rubella vaccine
WO1993020834A1 (en) 1992-04-10 1993-10-28 Brigham And Women's Hospital Methods and compositions for oral delivery of therapeutic agents
US5534496A (en) 1992-07-07 1996-07-09 University Of Southern California Methods and compositions to enhance epithelial drug transport
EP0750630A4 (en) * 1994-03-11 1998-01-07 Ariad Pharma Inc METHOD AND MATERIALS FOR IDENTIFYING INHIBITORS OF MOLECULAR INTERACTIONS, WHICH ARE BROUGHT BY THE SH3 DOMAINS
US5831008A (en) * 1994-08-18 1998-11-03 La Jolla Cancer Research Foundation Retinoblastoma protein-interacting zinc finger proteins
US6086875A (en) 1995-01-17 2000-07-11 The Brigham And Women's Hospital, Inc. Receptor specific transepithelial transport of immunogens
US6030613A (en) 1995-01-17 2000-02-29 The Brigham And Women's Hospital, Inc. Receptor specific transepithelial transport of therapeutics
IE80466B1 (en) 1995-11-10 1998-07-29 Elan Corp Plc Peptides which enhance transport across tissues and methods of identifying and using the same
NZ322175A (en) * 1995-11-10 1999-02-25 Elan Corp Plc Peptides which enhance transport across tissues and methods of identifying the same
US6261787B1 (en) 1996-06-03 2001-07-17 Case Western Reserve University Bifunctional molecules for delivery of therapeutics
US6060082A (en) 1997-04-18 2000-05-09 Massachusetts Institute Of Technology Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
WO1998051325A2 (en) * 1997-05-15 1998-11-19 Cytogen Corporation Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
JP4799790B2 (ja) * 1999-09-27 2011-10-26 メリオン リサーチ スリー リミテッド 膜転位ペプチド、同ペプチドを含有する組成物、同ペプチドを含有する医薬製剤及び同ペプチドの製剤の調製における使用
JP2001245675A (ja) * 1999-12-28 2001-09-11 Kyogo Ito 腫瘍抗原
CN1323825A (zh) * 2000-05-16 2001-11-28 上海博德基因开发有限公司 一种新的多肽——人网格蛋白轻链9和编码这种多肽的多核苷酸
AU2002254161A1 (en) * 2001-03-12 2002-09-24 Montana State University-Bozeman M cell directed vaccines
EP1419252A2 (en) * 2001-04-04 2004-05-19 Merrion Research I Limited Genetic analysis of peyers's patches and m cells and methods and compositions targeting peyer's patches and m cell receptors
ATE414100T1 (de) * 2001-07-02 2008-11-15 Merrion Res Iii Ltd Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen

Also Published As

Publication number Publication date
ATE414100T1 (de) 2008-11-15
JP2005503782A (ja) 2005-02-10
AU2002326070A1 (en) 2003-01-21
US7485321B2 (en) 2009-02-03
EP1432729A2 (en) 2004-06-30
WO2003004517A2 (en) 2003-01-16
US6916789B2 (en) 2005-07-12
EP1432729B1 (en) 2008-11-12
CA2451741A1 (en) 2003-01-16
US20050227924A1 (en) 2005-10-13
US20100016549A1 (en) 2010-01-21
CA2451741C (en) 2014-02-18
US20030096354A1 (en) 2003-05-22
DE60229867D1 (de) 2008-12-24
WO2003004517A3 (en) 2004-04-29

Similar Documents

Publication Publication Date Title
US20100016549A1 (en) Peyer's patch and/or m-cell targeting ligands
CN102481341B (zh) 蛋白原及其使用方法
US7563866B2 (en) Modular antigen transporter molecules (MAT molecules) for modulating immune reactions, associated constructs, methods and uses
Rafferty et al. Peptide therapeutics and the pharmaceutical industry: barriers encountered translating from the laboratory to patients
JP3830525B2 (ja) 組織横断輸送を強化するペプチドとその同定法および使用法
KR101216008B1 (ko) 바이포달 펩타이드 바인더
JP2025137626A (ja) 安定化ペプチドによって介在される標的タンパク質の分解
Siebert et al. Tuftsin-properties and analogs
Higgins et al. In vivo phage display to identify M cell-targeting ligands
KR20120125455A (ko) 세포내 타겟 결합용 바이포달 펩타이드 바인더
JP6218175B2 (ja) ヘルパーｔ細胞誘導性ポリペプチドの改変
US20130109616A1 (en) Antimicrobial peptides
JP2005503782A5 (https=)
US20130059793A1 (en) Egf receptor mimicking peptides
CN109310729A (zh) 用于改善转染效率的合成化合物
US20050277575A1 (en) Therapeutic compositions and methods for treating diseases that involve angiogenesis
WO2013165262A1 (en) Peptides, constructs and uses therefor
US20250304623A1 (en) Peptides for intracellular delivery
JP4238557B2 (ja) ハイモビリティーグループタンパクと親和性を有するペプチド
WO2013149237A1 (en) Targeting intracellular organelle zip codes with functional homing ligands from cell-internalizing phage combinatorial libraries
CN113557246A (zh) 靶向αvβ3整联蛋白的单域抗体
Huang Bioactive peptides from the defensive skin secretions of selected American and Asian frogs
Mihara et al. Designed Peptide Libraries for Cell Analyzing Microarrays
CN106749536A (zh) 一种黏膜胞转受体gp‑2的高亲和性寡肽及其应用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050624

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050624

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20061212

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080603

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20080822

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081024

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20081031

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081216

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090316

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090324

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090605

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090804

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090812

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090915

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090924

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121002

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131002

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees